000 01314 a2200373 4500
005 20250514164918.0
264 0 _c20040504
008 200405s 0 0 eng d
022 _a1075-2765
024 7 _a10.1097/00045391-200401000-00012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPosadas, Edwin M
245 0 0 _aThe emerging role of bisphosphonates in prostate cancer.
_h[electronic resource]
260 _bAmerican journal of therapeutics
_c
300 _a60-73 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAnimals
650 0 4 _aBone Neoplasms
_xdrug therapy
650 0 4 _aBone Remodeling
650 0 4 _aBreast Neoplasms
_xpathology
650 0 4 _aCohort Studies
650 0 4 _aDiphosphonates
_xadverse effects
650 0 4 _aDisease Progression
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOsteoporosis
_xdrug therapy
650 0 4 _aPain
_xdrug therapy
650 0 4 _aProstatic Neoplasms
_xcomplications
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aDahut, William L
700 1 _aGulley, James
773 0 _tAmerican journal of therapeutics
_gvol. 11
_gno. 1
_gp. 60-73
856 4 0 _uhttps://doi.org/10.1097/00045391-200401000-00012
_zAvailable from publisher's website
999 _c14433971
_d14433971